Global Rank
#17475
Country Rank
#5359
Market Cap
308.5 M
Price
1.13
Change (%)
1.34%
Volume
11.07 M
Hunan Nucien Pharmaceutical's latest marketcap:
308.5 M
As of 07/06/2025, Hunan Nucien Pharmaceutical's market capitalization has reached $308.5 M. According to our data, Hunan Nucien Pharmaceutical is the 17475th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 308.5 M |
Revenue (ttm) | 23.39 M |
Net Income (ttm) | -53,511,276.28 |
Shares Out | 272.83 M |
EPS (ttm) | -0.2 |
Forward PE | 0.00 |
Ex-Dividend Date | n/a |
Earnings Date | 08/29/2025 |
Market Cap Chart
Data Updated: 07/06/2025
Hunan Nucien Pharmaceutical's yearly market capitalization.
Hunan Nucien Pharmaceutical has seen its market value drop from ¥6.84 B to ¥308.5 M since 2020, representing a total decrease of 95.49% and an annual compound decline rate (CAGR) of 49.68%.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/06/2025 | ¥308.5 M | 23.85% | 17475 |
12/31/2024 | ¥1.78 B | -31.04% | 17728 |
12/29/2023 | ¥2.59 B | -23.51% | 15152 |
12/30/2022 | ¥3.38 B | -31.39% | 12389 |
12/31/2021 | ¥4.93 B | -27.96% | 10767 |
12/31/2020 | ¥6.84 B | 7749 |
Company Profile
About Hunan Nucien Pharmaceutical Co., Ltd.
Hunan Nucien Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the research, development, production, and sale of chemical drugs in China.
Key Focus Areas
The company operates in multiple therapeutic fields, including:
- Anti-influenza
- Malignant tumors
- Cardiovascular diseases
- Antibiotics
- Antipyretics and pain relief
- Diabetes management
- Analgesics
- Cerebrovascular treatments
- Respiratory medications
Company Background
Founded in 2006, Hunan Nucien Pharmaceutical Co., Ltd. is headquartered in Guangzhou, China.
Frequently Asked Questions
-
What is Hunan Nucien Pharmaceutical's (SHA-688189) current market cap?As of 07/06/2025, Hunan Nucien Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $308.5 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hunan Nucien Pharmaceutical (SHA-688189) rank globally by market cap?Hunan Nucien Pharmaceutical global market capitalization ranking is approximately 17475 as of 07/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.